Ironwood Pharmaceuticals Inc (NAS:IRWD)
$ 4.51 -0.01 (-0.22%) Market Cap: 720.42 Mil Enterprise Value: 1.26 Bil PE Ratio: 112.75 PB Ratio: 0 GF Score: 55/100

Q4 2019 Ironwood Pharmaceuticals Inc Earnings Call Transcript

Feb 13, 2020 / 01:30PM GMT
Release Date Price: $13.07 (+4.90%)
Operator

Ladies and gentlemen, thank you for standing by, and welcome to the Ironwood Pharmaceuticals Fourth Quarter and Full Year 2019 Investor Update Conference Call. (Operator Instructions)

I would now like to hand the conference over to your speaker, Meredith Kaya. Ma'am, please go ahead.

Meredith Kaya
Ironwood Pharmaceuticals, Inc. - VP of IR & Corporate Communications

Good morning, and thanks for joining us for our fourth quarter and full year 2019 investor update. Our press release crossed the wire this morning and can be found on our website, www.ironwoodpharma.com. Today's call and accompanying slides include forward-looking statements. Such statements involve risks and uncertainties that may cause actual results to differ materially. A discussion of these statements and risk factors is available on the current safe harbor statement slide as well as under the heading Risk Factors in our quarterly report on Form 10-Q for the quarter ended September 30, 2019, and in our future

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot